These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31789348)

  • 1. Ergocalciferol improves endothelial vasodilatory and vasoconstrictor function in an in vivo model of mild uraemia.
    Dreyer G; Kieswich J; Harwood S; Ahluwalia A; Yaqoob MM
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31789348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ergocalciferol and microcirculatory function in chronic kidney disease and concomitant vitamin d deficiency: an exploratory, double blind, randomised controlled trial.
    Dreyer G; Tucker AT; Harwood SM; Pearse RM; Raftery MJ; Yaqoob MM
    PLoS One; 2014; 9(7):e99461. PubMed ID: 25006678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
    Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
    J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria.
    Susantitaphong P; Nakwan S; Peerapornratana S; Tiranathanagul K; Katavetin P; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    BMC Nephrol; 2017 Jan; 18(1):19. PubMed ID: 28088187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paricalcitol and endothelial function in chronic kidney disease trial.
    Zoccali C; Curatola G; Panuccio V; Tripepi R; Pizzini P; Versace M; Bolignano D; Cutrupi S; Politi R; Tripepi G; Ghiadoni L; Thadhani R; Mallamaci F
    Hypertension; 2014 Nov; 64(5):1005-11. PubMed ID: 25259743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4-5.
    Gravesen E; Hofman-Bang J; Lewin E; Olgaard K
    Scand J Clin Lab Invest; 2013 Mar; 73(2):107-16. PubMed ID: 23281842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of exercise training on aortic tone in chronic renal insufficiency.
    Shelkovnikov S; Summers SM; Elahimehr R; Adams G; Purdy RE; Vaziri ND
    Am J Hypertens; 2008 May; 21(5):564-9. PubMed ID: 18437148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Angiotensin II Receptor Blockade Limits Hypertension, Aortic Dysfunction, and Structural Remodeling in a Rat Model of Chronic Kidney Disease.
    Ameer OZ; Butlin M; Kaschina E; Sommerfeld M; Avolio AP; Phillips JK
    J Vasc Res; 2016; 53(3-4):216-229. PubMed ID: 27880955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D Attenuates Endothelial Dysfunction in Uremic Rats and Maintains Human Endothelial Stability.
    Vila Cuenca M; Ferrantelli E; Meinster E; Pouw SM; Kovačević I; de Menezes RX; Niessen HW; Beelen RHJ; Hordijk PL; Vervloet MG
    J Am Heart Assoc; 2018 Sep; 7(17):e008776. PubMed ID: 30371149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum phosphate modifies the vascular response to vitamin D receptor activation in chronic kidney disease (CKD) patients.
    Zoccali C; Torino C; Curatola G; Panuccio V; Tripepi R; Pizzini P; Versace M; Bolignano D; Cutrupi S; Ghiadoni L; Thadhani R; Tripepi G; Mallamaci F
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):581-589. PubMed ID: 27113290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of vitamin D deficiency in CKD patients with ergocalciferol: are current K/DOQI treatment guidelines adequate?
    Qunibi WY; Abdellatif A; Sankar S; Hamdan Z; Lin FY; Ingle J; Cadena A; Gelfond J; Kasinath B
    Clin Nephrol; 2010 Apr; 73(4):276-85. PubMed ID: 20353735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.
    Noonan W; Koch K; Nakane M; Ma J; Dixon D; Bolin A; Reinhart G
    Nephrol Dial Transplant; 2008 Dec; 23(12):3824-30. PubMed ID: 18644798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
    Wetmore JB; Kimber C; Mahnken JD; Stubbs JR
    Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Effect of Ergocalciferol on Bone Metabolism Indexes and Parathyroid Hormone in Hemodialysis Patients.
    Bashardoust B; Zakeri A; Fouladi N; Izadi Z; Hosseini F
    Iran J Kidney Dis; 2018 Nov; 12(6):359-363. PubMed ID: 30595565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different vitamin D receptor agonists exhibit differential effects on endothelial function and aortic gene expression in 5/6 nephrectomized rats.
    Wu-Wong JR; Li X; Chen YW
    J Steroid Biochem Mol Biol; 2015 Apr; 148():202-9. PubMed ID: 25500070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.
    Wu-Wong JR; Kawai M; Chen YW; Nakane M
    Br J Pharmacol; 2011 Sep; 164(2b):551-60. PubMed ID: 21557735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL; Hristova M; Ho LT; Sprague SM
    Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
    Blair D; Byham-Gray L; Lewis E; McCaffrey S
    J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dietary vitamin E supplementation on vascular reactivity of thoracic aorta in streptozotocin-diabetic rats.
    Cinar MG; Ulker S; Alper G; Evinç A
    Pharmacology; 2001 Jan; 62(1):56-64. PubMed ID: 11150923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease.
    DeVille J; Thorp ML; Tobin L; Gray E; Johnson ES; Smith DH
    Nephrology (Carlton); 2006 Dec; 11(6):555-9. PubMed ID: 17199797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.